These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6424459)

  • 1. Prolonged interval high-dose intravenous immunoglobulin in patients with primary immunodeficiency states.
    Montanaro A; Pirofsky B
    Am J Med; 1984 Mar; 76(3A):67-72. PubMed ID: 6424459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of high-dose and low-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency diseases.
    Ochs HD; Fischer SH; Wedgwood RJ; Wara DW; Cowan MJ; Ammann AJ; Saxon A; Budinger MD; Allred RU; Rousell RH
    Am J Med; 1984 Mar; 76(3A):78-82. PubMed ID: 6424461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I study of intravenous gamma globulin in multiple myeloma.
    Gordon DS; Hearn EB; Spira TJ; Reimer CB; Phillips DJ; Schable C
    Am J Med; 1984 Mar; 76(3A):111-6. PubMed ID: 6424442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Build-up maintenance of IgG serum concentrations with intravenous immunoglobulin in patients with primary humoral immunodeficiency.
    Morell A; Schnoz M; Barandun S
    Vox Sang; 1982; 43(4):212-9. PubMed ID: 7135889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immune globulin therapy in hypogammaglobulinemia. A review.
    Pirofsky B
    Am J Med; 1984 Mar; 76(3A):53-60. PubMed ID: 6424457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immune globulin therapy. Treatment of a patient with severe immunodeficiency, chronic malabsorption, and fulminant septicemia.
    Gonzalez EB; Guernsey BG; Ingrim NB; Ichikawa Y; Daniels JC
    Arch Intern Med; 1985 May; 145(5):945-6. PubMed ID: 3922322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a new chemically modified intravenous IgG preparation in severe primary humoral immunodeficiency: clinical efficacy and attempts to individualize dosage.
    Schiff RI; Rudd C; Johnson R; Buckley RH
    Clin Immunol Immunopathol; 1984 Apr; 31(1):13-23. PubMed ID: 6421523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Variable immune deficiency syndrome with antibody deficiency--long-term substitution with immunoglobulins].
    Vaith P; Maas D
    Immun Infekt; 1984 Apr; 12(2):123-8. PubMed ID: 6442916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of high-dose intravenous immune globulin therapy for antibody deficiency syndromes.
    Sorensen RU; Polmar SH
    Am J Med; 1984 Mar; 76(3A):83-90. PubMed ID: 6424462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of the safety of three intravenous immunoglobulin preparations in patients with primary hypogammaglobulinaemia.
    Yap PL; McClelland DB
    J Infect; 1986 Jan; 12(1):5-10. PubMed ID: 3082994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalized Therapy: Immunoglobulin Replacement for Antibody Deficiency.
    Wasserman RL
    Immunol Allergy Clin North Am; 2019 Feb; 39(1):95-111. PubMed ID: 30466775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous gamma globulin in the treatment of chronic idiopathic thrombocytopenic purpura in adults.
    Oral A; Nusbacher J; Hill JB; Lewis JH
    Am J Med; 1984 Mar; 76(3A):187-92. PubMed ID: 6424449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anaphylactic shock reaction following intravenous administration of 7S immunoglobulin in patients with hypogammaglobulinemia, especially in children with acute lymphoblastic leukemia (ALL)].
    Manzke H; Seifert J
    Klin Padiatr; 1987; 199(4):274-8. PubMed ID: 3116320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous gamma globulin treatment for chronic idiopathic thrombocytopenic purpura in children.
    Warrier I; Lusher JM
    Am J Med; 1984 Mar; 76(3A):193-8. PubMed ID: 6424451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replacement therapy with modified immunoglobulin G in burn patients: preliminary kinetic studies.
    Shirani KZ; Vaughan GM; McManus AT; Amy BW; McManus WF; Pruitt BA; Mason AD
    Am J Med; 1984 Mar; 76(3A):175-80. PubMed ID: 6424447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of a monomeric, functionally intact intravenous IgG preparation in patients with primary immunodeficiency syndromes.
    Eibl MM; Cairns L; Rosen FS
    Clin Immunol Immunopathol; 1984 Apr; 31(1):151-60. PubMed ID: 6421524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of intravenous immune globulin in pregnant women with common variable hypogammaglobulinemia.
    Sorensen RU; Tomford JW; Gyves MT; Judge NE; Polmar SH
    Am J Med; 1984 Mar; 76(3A):73-7. PubMed ID: 6424460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse reactions in selected patients following intravenous infusions of gamma globulin.
    Day NK; Good RA; Wahn V
    Am J Med; 1984 Mar; 76(3A):25-32. PubMed ID: 6231860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Varicella zoster antibody titers after the administration of intravenous immune serum globulin or varicella zoster immune globulin.
    Paryani SG; Arvin AM; Koropchak CM; Wittek AE; Amylon MD; Dobkin MB; Budinger MD
    Am J Med; 1984 Mar; 76(3A):124-7. PubMed ID: 6324585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High- vs low-dose immunoglobulin therapy in the long-term treatment of X-linked agammaglobulinemia.
    Liese JG; Wintergerst U; Tympner KD; Belohradsky BH
    Am J Dis Child; 1992 Mar; 146(3):335-9. PubMed ID: 1543181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.